TCTMD: Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

As TAVI outcomes have improved over the years, different factors seem to be driving changes in short-term complications and mortality, according to data from the Society of Thoracic Surgeons/American College of Cardiology TVT Registry.

Suzanne V. Arnold, MD (Saint Luke’s Mid America Heart Institute/University of Missouri-Kansas City), who presented an analysis of 30-day and 1-year outcomes for TAVIs performed between 2011 and 2018 in a late-breaking session on Sunday, pointed out that many aspects of TAVI have evolved. The patients themselves became younger and healthier, for instance, while use of femoral access grew, sheath sizes shrank, use of general anesthesia waned, contrast volumes decreased, and new valve designs entered the scene.

"We believe that [our] findings emphasize the importance of device iterations and nondevice procedural factors to improving short-term mortality and complications of TAVR," Arnold said. 

Read the full TCTMD article: Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

Related Content

Aug. 22, 2022

TCTMD: Even With Revascularization in ISCHEMIA, Skipping Meds Hurt Health Status

Medication nonadherence was common and associated with worse health status among the patients with stable coronary disease in the ISCHEMIA trial, r

Nov. 9, 2021

tctMD: SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

After 2 years, clinical outcomes were similar, hemodynamics favored TAVI, and paravalvular leak favored surgery.
Oct. 1, 2020

Healio: No difference in sustained health status improvements in TAVR vs. surgical AVR

Patients who had TAVR had similar health status after five years with those who had surgical AVR, according to a new study by Dr. Suzanne Arnold.